#Drug Safety and Recalls
Articles tagged "Drug Safety and Recalls"
Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know
New research reveals concerning links between gabapentin use in chronic pain patients and increased dementia risk. Essential reading for pharmacists and healthcare providers.
FDA Removes REMS Program for Clozapine Despite Neutropenia Risk
FDA eliminates mandatory safety program for clozapine, citing access concerns while acknowledging ongoing neutropenia risk for patients.